- The trend backdrop is active with a 43-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is constructive, supporting the smart-money activity read.
SPRINT
STO
Week ended 07 Aug 2026
Weekly Investor Report
Sprint Bioscience AB (publ) · Healthcare · Biotechnology
Latest close
3.50 SEK
-2.8%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 17.9% above the Trend Line and sits at 73.3% of its 52-week range. The latest completed week returned -2.8%, after a -9.3% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
47
out of 100
Latest Close
3.50 SEK
7 Aug 2026
1W Return
-2.8%
latest completed week
4W Return
-9.3%
short-term follow-through
12W Return
-3.3%
quarterly tape
Trend Breadth
82.7%
43 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 42.92% based on similar historical setup states.
- 2 reversal markers appear in the recent smart-money tape.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.8%
Latest completed week; four-week move -9.3%.
Indicator stack
90/13
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.92%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
15 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 17.9% above the Trend Line and sits at 73.3% of its 52-week range. The latest completed week returned -2.8%, after a -9.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8812-week average 0.96
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.88Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -9.3% over four weeks, -3.3% over 12 weeks, and 483.3% over one year. The current trend has remained active for 43 consecutive weeks.
Performance by holding period
Active trend streak43 weeks
Active weeks in one year43
Trend breadth82.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.86Latest activity-pressure read.
Pressure change-267.6%Four-week change in activity pressure.
Leadership53.58Latest relative-leadership reading.
RS change-44.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 15 relevant articles.
0 positive · 15 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-23.7%Distance below the 52-week high.
13-week volatility7.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2612 weeks finished lower.
Best week+46.4%Week of 10 Apr.
Worst week-13.0%Week of 24 Apr.
Latest week-2.8%Week of 7 Aug.
Shape of recent returns
Strong gains10
Modest gains3
Flat weeks1
Modest losses3
Sharp losses9
Recent vol7.7%13-week weekly-return volatility.
Base vol21.2%52-week weekly-return volatility.
Up/down split26/24Count of positive and negative weeks in the 52-week window.
Average skew14.3% / -5.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank84 / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Biotechnology
4-week rank46 / 58
Group average3.5%
Trend breadth39.7%
Trend39.7%active weekly trend signals
MD53.4%positive activity pressure
RS22.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape53/100
Trend, activity pressure, participation, and risk combine to a 53/100 tape read.
Indicator analysis80/100Latest 12-week confirmation: trend 12/12, activity pressure 9/12, relative leadership 12/12.
Activity pressure 0.88; 2 reversal markers Next-Week ExpectancyNegative 42.92%Next-week expectancy is negative with a 42.92% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 15 relevant articles.
Drivers from Nebraska, Western Australia & North Dakota grab weekend sprint specials Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 3.50 SEK | -2.8% | 2.97 SEK | 1.56 SEK | -0.86 | 53.58 | 976.1K | On |
| 31 Jul 2026 | 3.60 SEK | -1.6% | 2.90 SEK | 1.55 SEK | -0.65 | 64.96 | 936.9K | On |
| 24 Jul 2026 | 3.66 SEK | 0.0% | 2.83 SEK | 1.53 SEK | -0.36 | 74.66 | 944.4K | On |
| 17 Jul 2026 | 3.66 SEK | -5.2% | 2.76 SEK | 1.51 SEK | 0.08 | 82.55 | 905.2K | On |
| 10 Jul 2026 | 3.86 SEK | -5.2% | 2.69 SEK | 1.48 SEK | 0.51 | 96.33 | 1.5M | On |
| 3 Jul 2026 | 4.07 SEK | -8.5% | 2.61 SEK | 1.46 SEK | 0.65 | 109.22 | 155.4K | On |
| 26 Jun 2026 | 4.45 SEK | 1.4% | 2.52 SEK | 1.44 SEK | 0.63 | 143.75 | 183.1K | On |
| 19 Jun 2026 | 4.39 SEK | 19.3% | 2.43 SEK | 1.42 SEK | 0.57 | 148.47 | 2.6M | On |
| 12 Jun 2026 | 3.68 SEK | 7.3% | 2.30 SEK | 1.39 SEK | 0.44 | 121.62 | 354.5K | On |
| 5 Jun 2026 | 3.43 SEK | -1.2% | 2.20 SEK | 1.37 SEK | 0.61 | 114.14 | 723.9K | On |
| 29 May 2026 | 3.47 SEK | 6.1% | 2.11 SEK | 1.35 SEK | 0.88 | 122.93 | 3.2M | On |
| 22 May 2026 | 3.27 SEK | -9.7% | 2.02 SEK | 1.33 SEK | 0.97 | 117.39 | 2.8M | On |
| 15 May 2026 | 3.62 SEK | -9.3% | 1.93 SEK | 1.32 SEK | 1.10 | 158.18 | 2.4M | On |
| 8 May 2026 | 3.99 SEK | 28.3% | 1.84 SEK | 1.30 SEK | 1.25 | 193.59 | 4.3M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.